No Data
No Data
Peak Bio Merges With Akari, Restructures Leadership
10-Q: Q3 2024 Earnings Report
Express News | Akari Therapeutics PLC - Merger to Result in 50% Equity Ownership for Akari and Peak Bio Shareholders
Express News | Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
Press Release: Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
Peak Bio Incentivizes Leadership With Stock Options for Growth
No Data
No Data